A TIME-TRADE-OFF STUDY OF HEALTH-RELATED QUALITY OF LIFE ADVANTAGE OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC TREATMENT FOR SCHIZOPHRENIA

被引：0
|
作者：
Osborne, R. H. [1 ]
Dalton, A. [2 ]
Hertel, J. [3 ]
Schrover, R. [4 ,5 ]
Smith, Kingsford D. [4 ]
机构：
[1] Deakin Univ, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Janssen Cilag Pty Ltd, N Ryde, NSW, Australia
[4] Janssen Cilag Pty Ltd, Sydney, NSW, Australia
[5] Decisionanalyt Pty Ltd, Sydney, NSW, Australia
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.1074
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A194 / A195
页数：2
相关论文
共 50 条
  • [1] Health-related quality of life advantage of long-acting injectable antipsychotic treatment for schizophrenia: a time trade-off study
    Richard H Osborne
    Andrew Dalton
    Judy Hertel
    Rudolf Schrover
    Dell Kingsford Smith
    [J]. Health and Quality of Life Outcomes, 10
  • [2] Health-related quality of life advantage of long-acting injectable antipsychotic treatment for schizophrenia: a time trade-off study
    Osborne, Richard H.
    Dalton, Andrew
    Hertel, Judy
    Schrover, Rudolf
    Smith, Dell Kingsford
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2012, 10
  • [3] Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone
    Nasrallah, HA
    Duchesne, I
    Mehnert, A
    Janagap, C
    Eerdekens, M
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (04) : 531 - 536
  • [4] Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM
    Litman, Robert
    Naber, Dieter
    Anta, Lourdes
    Martinez, Javier
    Filts, Yuriy
    Correll, Christoph U.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 219 - 232
  • [5] Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
    Eun Ji Park
    Sarmila Amatya
    Myung Sun Kim
    Jong Hoon Park
    Eunyoung Seol
    Heeyong Lee
    Young-Hee Shin
    Dong Hee Na
    [J]. Archives of Pharmacal Research, 2013, 36 : 651 - 659
  • [6] Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
    Park, Eun Ji
    Amatya, Sarmila
    Kim, Myung Sun
    Park, Jong Hoon
    Seol, Eunyoung
    Lee, Heeyong
    Shin, Young-Hee
    Na, Dong Hee
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (06) : 651 - 659
  • [7] Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone (vol 65, pg 531, 2004)
    Nasrallah, HA
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (08) : 1150 - 1150
  • [8] Long-acting, injectable risperidone - the first long-acting, atypical antipsychotic - improves quality of life
    Nasrallah, H
    Duchesne, I
    Mehnert, A
    Janagap, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S282 - S282
  • [9] Adherence Challenges and Long-Acting Injectable Antipsychotic Treatment in Patients with Schizophrenia
    Morton, N. Kirk
    Zubek, Donna
    [J]. JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2013, 51 (03) : 13 - 18
  • [10] Long-acting injectable antipsychotic in first-episode schizophrenia: The EONKCS Study
    Chiliza, B.
    Asmal, L.
    Emsley, R.
    [J]. SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2014, 20 (03) : 97 - 97
12345